Ken Griffin Landec Corp \Ca\ Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	N/A	-25,600 Reduced 85.91%	4,200 $0
Q1 2024 May 15, 2024	BUY	N/A	29,800 New	29,800 $0
Q3 2023 Nov 14, 2023	SELL	N/A	-8,200 Reduced 19.43%	34,000 $0
Q2 2023 Aug 14, 2023	BUY	N/A	16,700 Added 65.49%	42,200 $0
Q1 2023 May 15, 2023	BUY	N/A	22,300 Added 696.88%	25,500 $0
Q4 2022 Feb 14, 2023	BUY	$0.0 - $9.95 $0 - $31,839	3,200 New	3,200 $0

20.4M

65.8K

14.1K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.